Hippo walks into its third-quarter report carrying the weight of its own optimism. Three months ago, management raised full-year guidance on every line it tracks, cut its combined ratio target by four points, pulled its $2 billion premium milestone forward to 2027 and lifted its 2028 profit goal. That was the most confident call in recent memory. This report is the first chance to see whether that confidence was earned or front-loaded.
The Street expects earnings of $0.32 per share on revenue of $154.7 million. That revenue figure would be a 28.2% gain from a year ago and a step up from the $144.7 million posted last quarter, which is solid growth for an insurer. The per-share estimate looks modest next to last quarter's $0.54 and the year-ago $0.44, and the Earnings Whisper of $0.40 suggests the informal bar sits meaningfully above consensus. There is good reason for caution in the published number. Hippo ran a 97.5% combined ratio through the first half, yet guided to 99% to 101% for the full year. That gap implies management left itself room for a weaker back half, whether from catastrophes or other loss pressure. A quarter that comes in well below that ceiling would argue the guidance is conservative.
On revenue, the setup is straightforward. Management now calls for $580 million to $585 million for 2026, up from $560 million to $570 million. The full-year consensus of $568.5 million sits below the low end of that new range, which suggests some estimates have not fully caught up. If Hippo simply delivers on its own outlook, top-line upside looks more likely than downside. Another raise would be a stronger signal, especially after the guide was already lifted twice.
The operating story rests on a few specific threads. The first is the hybrid fronting platform, which has doubled to more than 50 programs. Gross written premium growth accelerated from 33% to 61% over the past four quarters. Any sign of that pace stalling would undercut the new 2028 targets. The second is the Accelerant partnership, announced in June with more than $500 million in expected 2027 premium. This quarter may not show much revenue from it, but early commentary on onboarding and timing will indicate whether the 2027 pull-forward is realistic. The third is expense leverage. The net expense ratio fell from 51.5% to 45.4% in one quarter, which management credited to AI tools rolling out across the workforce. Holding most of that gain would suggest the improvement is structural rather than a one-quarter bump.
The risks flagged last time remain live. Casualty is now the largest gross line, and Hippo plans to keep more of it, lifting retention toward the mid-teens from 3% last year. That adds net exposure to a younger, longer-tail book just as prior-year reserve releases have shrunk to 2% from roughly 7%. Softening competition in excess and surplus homeowners and commercial property could further slow an already modest homeowners line. The reinsurance overhaul, which cut probable maximum losses by more than 30%, should help cushion catastrophe results. This quarter will show how well it works.
The market has already bought in. Shares have climbed 16.7% since the last report, beating the S&P 500 by more than 12 points. The stock sits at its post-earnings high of $37.33, well above its 200-day average near $29, and is testing a breakout. Sentiment has swung from mildly bearish to mildly bullish. That leaves less room for a merely in-line print. The central question is whether Hippo's sharp margin improvement holds as it takes on more casualty risk. If loss ratios stay disciplined while premium keeps compounding, the bullish case built last quarter remains intact.